From Seekingalpha · · 30s
Abeona Therapeutics Q3 2026 Earnings Call
Abeona Therapeutics reports Q3 2026 earnings with acquisition of APT-1011.
In brief
Abeona Therapeutics reports Q3 2026 earnings with acquisition of APT-1011. Abeona Therapeutics acquired APT-1011 in Q3 2026 as part of its financial results. Originally reported by Seekingalpha.
Earnings Call Announcement
Abeona Therapeutics held Q3 2026 earnings call on November 9, 2026.
Acquisition of APT-1011
Company announced acquisition of APT-1011 as part of Q3 2026 financial results.
Leadership Present
Gregory Gin, Vishwas Seshadri, Madhav Vasanthavada, and Joseph Vazzano participated in call.
The big picture
Abeona Therapeutics acquired APT-1011 in Q3 2026 as part of its financial results.
